explore IL-33 expression in PCa using bioinformatics analyses (TCGA, TIMER, HPA databases), followed by validation in clinical samples (PCa, benign prostatic hyperplasia [BPH], and non-cancerous tissues) (14). This evidence concerns the gene IL33 and posterior cortical atrophy.